China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)

Market Cap	42.70B -23.0%
Revenue (ttm)	32.88B +21.0%
Net Income	3.23B -1.4%
EPS	1.94 -0.9%
Shares Out	1.66B
PE Ratio	13.22
Forward PE	11.19
Dividend	1.04 (4.05%)
Ex-Dividend Date	n/a

Volume	11,511,203
Average Volume	13,583,723
Open	25.75
Previous Close	25.72
Day's Range	25.60 - 25.80
52-Week Range	25.64 - 33.45
Beta	0.12
RSI	26.01
Earnings Date	Apr 25, 2026

About SHE:000999

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, anti-infection, and other treatment areas; Chi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 30,304
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000999

Financial Performance

In 2025, SHE:000999's revenue was 31.60 billion, an increase of 14.43% compared to the previous year's 27.62 billion. Earnings were 3.42 billion, an increase of 1.58%.